After a successful 2021 in terms of CSR, M2i continues its efforts and sets new objectives

M2i Group has obtained the registration of several of its biological crop protection solutions. The registration includes three market authorizations for finished products, two for pheromone active ingredients, and several existing European market authorization extensions.

The government has appointed us among the 31 winners of its industrial recovery plan thanks to our project to produce an active pharmaceutical ingredient (API) within our production site in Salin-de-Giraud (13). This API has been widely used this year in the management of intensive care patients suffering from Covid-19.